September 20, 2014 7:05 PM ET

Pharmaceuticals

Company Overview of Medlennium Technologies, Inc.

Executive Profile

Keith L. Black M.D.

Chairman of the Board and Chief Scientific Officer, Medlennium Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 8 different industries.

See Board Relationships
----

Background

Dr. Keith L. Black, M.D. co-founded Imagine Pharmaceuticals Inc. and serves as its Lead Scientist. Dr. Black serves as Chief Scientific Officer of Medlennium Technologies Inc. He served on the University of California, Los Angeles faculty for 10 years where he was Professor of Neurosurgery. He served as the Head of the UCLA Comprehensive Brain Tumor Program. He is an internationally recognized neurosurgeon and scientist. He pioneered research on designing ways to open ...

Corporate Headquarters

924 Westwood Boulevard
Los Angeles, California 90024

United States

Phone: --
Fax: --

Board Members Memberships

Co-Founder, Lead Scientist and Director

Education

Bachelor's Degree
University of Michigan
MD
University of Michigan

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Medlennium Technologies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.